AIP
MYOK

Ameritas Investment Partners’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Ameritas Investment Partners’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,323
Closed -$589K – 3128
2020
Q3 		$589K Sell
4,323
-68
-2% -$7.23K 0.03% 666
2020
Q2 		$424K Buy
4,391
+444
+11% +$37K 0.02% 754
2020
Q1 		$185K Buy
3,947
+140
+4% +$8.97K 0.01% 973
2019
Q4 		$277K Hold
3,807
– – 0.01% 923
2019
Q3 		$199K Hold
3,807
– – 0.01% 1058
2019
Q2 		$191K Buy
3,807
+985
+35% +$48K 0.01% 1090
2019
Q1 		$147K Hold
2,822
– – 0.01% 1231
2018
Q4 		$138K Hold
2,822
– – 0.01% 1178
2018
Q3 		$184K Buy
2,822
+256
+10% +$15.1K 0.01% 1138
2018
Q2 		$127K Buy
2,566
+1,050
+69% +$50.8K 0.01% 1376
2018
Q1 		$74K Hold
1,516
– – ﹤0.01% 1684
2017
Q4 		$64K Hold
1,516
– – ﹤0.01% 1778
2017
Q3 		$65K Hold
1,516
– – ﹤0.01% 1720
2017
Q2 		$20K Buy
1,516
+639
+73% +$8.42K ﹤0.01% 2467
2017
Q1 		$12K Buy
+877
New +$11.2K ﹤0.01% 2643

Ameritas Investment Partners's MYOK Position: Q4 2020 in Review

Ameritas Investment Partners sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 4,323 shares — an estimated $589K sold.

Ameritas Investment Partners first reported a position in MYOK in Q1 2017 and held it in 15 quarters. The position peaked at $589K in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Ameritas Investment Partners reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Ameritas Investment Partners sold 4,323 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $589K.
  • Ameritas Investment Partners first reported a position in MyoKardia, Inc. Common Stock in Q1 2017 and held it in 15 quarters.
  • Ameritas Investment Partners's MyoKardia, Inc. Common Stock position peaked at $589K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Ameritas Investment Partners's 13F filing for Q4 2020, filed 12 Feb 2021.